Tag: Leqembi
-
Lecanemab: Alzheimer’s Drug Gets Full FDA Approval
Globally, there are over 55 million people living with Alzheimer’s disease, and this figure is projected to hit 78 million by 2030 and 139 million by 2050. With global deaths from Alzheimer’s disease and other dementias nearly tripling over the past 30 years, there’s been an added incentive to find a cure to adequately address this crisis. Unfortunately, there…
-
Lecanemab: FDA Approval of New Alzheimer’s Drug Divides Experts
According to statistics, the number of people living with Alzheimer’s disease is projected to hit 78 million by 2030 and 139 million by 2050. With 1.55 million global deaths in 2019 attributed to dementia, a form of Alzheimer’s, researchers and organizations are desperately seeking out ways to address this crisis. Unfortunately, there is currently no cure…